RxDoctor Payments DataLook up a doctor →

Kandi Arwine

Family · Garden City, KSNPI 1801319181

Payments from drug & device makers

$12,098in general payments, 2019–2025

Across 315 payments — averaging $38.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bristol Myers Squibb$6K
  • Novartis$460
  • GSK$354
  • Genentech USA, Inc.$314
  • Sanofi$283
  • Merck$269
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$6,02399%
  • Education$751%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bristol Myers Squibb15$6,270
Novartis26$460
GSK17$354
Genentech USA, Inc.18$314
Sanofi12$283
Merck13$269
Gilead(2 entities)15$257
Johnson & Johnson(2 entities)16$251
E.r. Squibb & Sons, L.L.C.13$211
AstraZeneca10$209
Lilly USA, LLC9$206
Regeneron Healthcare Solutions, Inc.8$198
AVEO Pharmaceuticals, Inc.7$162
Amgen8$162
AbbVie7$148
Stemline Therapeutics Inc.8$147
Spectrum Pharmaceuticals Inc.8$144
Daiichi Sankyo Inc.7$137
Takeda Pharmaceuticals U.S.A., Inc.5$119
Pharmacosmos Therapeutics Inc.4$114
Sobi, Inc4$111
Incyte Corporation6$109
Pfizer6$106
Springworks Therapeutics, Inc.5$101
Tersera Therapeutics LLC4$95
Novocure Inc.3$92
Rigel Pharmaceuticals, Inc.6$81
Seagen Inc.5$75
Jazz Pharmaceuticals Inc.3$72
Pharmacyclics LLC, An Abbvie Company3$59
Beigene USA, Inc.4$59
Organon3$55
Apellis Pharmaceuticals, Inc.2$49
Kyowa Kirin, Inc.2$39
Astellas Pharma US Inc2$38
Ipsen Biopharmaceuticals, Inc2$36
Genmab U.S., Inc.2$33
Bayer2$33
Sumitomo Pharma America, Inc.2$32
Puma Biotechnology, Inc.2$32
Boehringer Ingelheim2$31
Recordati_rare_diseases_inc.1$28
Invivyd Inc1$26
Iovance Biotherapeutics, Inc.1$23
Adaptive Biotechnologies Corporation1$22
CTI Biopharma Corp.1$22
Geron Corporation1$21
Epizyme, Inc.1$19
EMD Serono, Inc.1$19
Alnylam Pharmaceuticals Inc.1$18
Taiho Oncology, Inc.1$17
Agios Pharmaceuticals, Inc.1$16
AMAG Pharmaceuticals, Inc.1$16
Acceleron Pharma, Inc.1$16
Exelixis Inc.1$15
Immunocore Limited1$15
Eagle Pharmaceuticals, Inc.1$14
Deciphera Pharmaceuticals Inc.1$14
Blueprint Medicines Corporation1$14
Myriad Genetic Laboratories, Inc.1$11

How this compares

$12,098 in reported general payments places this provider in the 95th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas →

Medicare billing

Part B allowed, 2024
$93,299
Medicare patients
446
Services billed
1,268

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron34$621
Letrozole27$607
Acyclovir22$503
Oxycodone Hcl15$419
Prochlorperazine Maleate29$365
Levothyroxine Sodium37$292
Hydroxyurea13$286
Anastrozole26$251
Tamoxifen Citrate11$197
Potassium Chloride26$174
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine12$87
Gabapentin16$70
Alendronate Sodium16$66
Allopurinol14$39

Paid to pharmacies, not to this prescriber.

Other family in Garden City

See the full list for Kansas →

Where these figures come from

Is this you, or does something look wrong? →